RELATED NEWS
Life Sciences PE: The Misunderstood Opportunity
Christoph Broja, Partner at EQT, dismantled the myth that biotech is too risky for private...
Democratizing Private Markets: The Seamless Revolution
Jocelyn Pidoux from iCapital, sat down to share how the industry is breaking down barriers and why...
No Blind Pool. No Waiting. Just Deals.
Artjom Jalosa, CEO of OVE Capital, introduced a model that challenges the very foundations of...